Insights · 5 min read
China's Clinical Trial Window Is Open. The Question Is Whether Your Structure Is Ready.
China leads in clinical trial volume, but advantage depends on HGR, CRO, and entity structure before the first patient is enrolled.
By Jack Wu, Partner





